Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New androgen and/or glucocorticoid receptor antagonists synthesized at Nuvation Bio

June 19, 2020

Nimbus Lakshmi identifies new TYK2 inhibitors

June 19, 2020

Merck & Co. discovers adenosine receptor A2A and/or A2B antagonists

June 19, 2020

Clinical activity seen with bomedemstat in phase II study in advanced myelofibrosis

June 19, 2020

ShanghaiTech University presents new estrogen receptor protein regulators

June 19, 2020

New phase I trial studies TQB-3474 in advanced malignant tumors

June 18, 2020

New MALT1 inhibitors discovered at Takeda

June 18, 2020

Phase I study of BAY-1436032 in advanced AML patients with mutant IDH1

June 18, 2020

HRAS-driven translation helps skin prevent tumors

June 18, 2020

Phase I results reported for BTK inhibitor TG-1701 in relapsed/refractory B-cell malignancies

June 17, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...